Open Access in the biomedical field - the rise of PloS ONE by Nathalie Duchange


Published on

To celebrate the Open Access Week 2012, MyScienceWork in partnership with UNESCO and UPMC organize for the first time in Paris, two events dedicated to Open Access.
Discover here the presentation of Nathalie Duchange (INSERM)

Published in: Education
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Open Access in the biomedical field - the rise of PloS ONE by Nathalie Duchange

  1. 1. Open Accessin the biomedical fieldThe rise of PLoS ONENathalie DuchangeInsermOctober 25, 2012
  2. 2. International movement born in the 1990sto allow the free dissemination of publicly-funded research
  3. 3. TWO GREENCOMPLEMENTARY OPEN REPOSITORIES ROUTES (institutional and disciplinary) Authors self-archive their scientific output GOLD AUTHOR-PAY TO PUBLISH- MODEL (Journals that provide OA) Articles are free to read, share, distribute, results may be re-used (authors keep their rights)
  4. 4. Specificities of the biomedical field thatimpact on both routes to Open Access
  5. 5. Central role of publication1 « Publish or Perish » Evaluation is based on publication in high quality peer-reviewed journals Journals’ quality is measured by the impact factor Impact: open repositories in life sicences collect mainly published articles
  6. 6. Conditions for archiving in Open Repositories depend on publishers and the extent of authors’rights transferred
  7. 7. A free open repository of biomedical and life sciences journal literature: PubMed Central2 Launched in 2000 by the U.S. National Institutes of Healths National Library of Medicine Direct access to the article (NIH/NLM) from PubMed (free ressource of citations) Impact: a reference in the field
  8. 8. Network : PubMed Central International UK PubMed Central to become Europe PubMed Central in november 2012
  9. 9. From HAL to PubMed Central Entry by dedicatedHAL is the French national portals, either multi-diciplinary and institutional, multi-institutional disciplinary or HAL-Inserm is the institutional Open Repository thematic portal for Inserm Part of HAL biomedical articles are transferred to PubMed Central (Depending on the publishers)
  10. 10. Gold RouteThe rise of Open Access Journals since 2000
  11. 11. What full Open Access means ?
  12. 12. PLoS: an Open Access Publisher Public Library of Science is a non profit publisher founded by leading scientists 7 high impact factor journals PLoS Biology, PLoS Computational Biology, PLoS Genetics, PLoS Medicine, PLoS Neglected Tropical Diseases. PLoS One, PLoS Pathogens. Revolution in the publishing model: introducing PLoS One
  13. 13. “Peer review is ostensibly one of the central pillars of modern science. A paper is not taken seriously by other scientists unless it is published in a “peerPLoS ONE reviewed” journal.” “But the truth is that peer review as practiced in the Revisiting 21st century biomedical research poisons science. It isPeer-Review conservative, cumbersome, capricious and intrusive.” Michael Eisen, co-funder of PLoS PLoS ONE Peer Review: - Papers have to be technically sound - Importance of the paper is let to the readearship
  14. 14. Acceptance rate: 70% Impact Factor > 4 Fast publication Received: July 12, 2012; Accepted: September 14, 2012; Published: October 17, 2012 Metrics PLoS ONEAttractivity for researchers
  15. 15. Will Open Access publishing kill quality? « Both scientists recently published in a PLOS open access journal with papers related to the research for which they were recognized by the Nobel Committee » « Since 2009, Shinya Yamanaka has published 9 papers in PLOS ONE »
  16. 16. Conclusion Opt for Green + GoldMost research organisations and funders have established OA mandates and/or policies that support both routes Gold OA accounts for approximatively 10% of the published articles The pay-to-publish model is not without financial risk
  17. 17. “The greatest benefit of openaccess publishing is wideningthe debate on scientificresearch; whats free to readand republish is also free todiscuss, dispute, and learnfrom” Kamran Abbasi J R Soc Med. 2012 May; 105(5): 185.
  18. 18. To learn more
  19. 19. Thank you for your attention ?